Inhibitors of Bcl-2 and Bruton’s tyrosine kinase synergize to abrogate diffuse large B-cell lymphoma (DLBCL) growth
Ontology highlight
ABSTRACT: Inhibitors of Bcl-2 and Bruton’s tyrosine kinase synergize to abrogate diffuse large B-cell lymphoma (DLBCL) growth
PROVIDER: PRJNA720831 | ENA |
REPOSITORIES: ENA
ACCESS DATA